North America held a dominant market position, capturing more than a 35.4% share, holding USD 2.49 billion in revenue.
A new randomized controlled trial has found promising evidence that the smoking cessation medication varenicline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback